The hidden gem at BioAgilytix is the extensive virological expertise. Decades of Executive and Lead Scientist experience in the antiviral drug discovery and development space has ensured the team can support any virological end point you may need. From classical virology including culture and PRNT to molecular quantitative and qualitative PCR, BioAgilytix can offer the full suite of virological endpoints for your clinical endpoints. In the molecular age, it can be challenging to find a team with cell culture-based virology expertise and when we combine our virology, immunology and molecular biology teams, BioAgilytix can support any end point required for vaccine or antiviral discovery and development. Physical containment 2 and 3 laboratories and training and access to physical containment 4 laboratories allow us to support any vaccine or antiviral agent in development.

Speak To A Scientist

    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.